Business & Investment

TSX ends flat

Canada’s largest center stake remained barely profitable by Tuesday’s closing price, largely supported by health care and cannabis issues.

TSX maintained a 2.42 point rise until it ended at 19,203.70 on Tuesday.

Canadian dollar was 79.81 cents US, 0.21 cents higher

In the cannabis sector, Aphria surpassed Monday’s closing price, rising $ 1.05 (6%) to $ 18.52 and OrganiGram Holdings up 10 cents (2.9%) to $ 3.60.

In gold, Nova Gold rose 76 cents (3.1%) to $ 11.83 and Alamos Gold rose 50 cents (5%) to $ 10.61.

In other resources, Lundin Mining was up 55 cents (4.2%) to $ 13.75 and Endeavor Silver was up 33 cents (5.1%) to $ 6.84.

Among energy stocks, MEG Energy fell 11 cents (1.6%) to $ 6.22 and Crescent Point Energy fell 8 cents (1.7%) to $ 4.78.

In the financial sector, Canaccord Genuity fell 27 cents (2.2%) to $ 11.83 and the Bank of Montreal fell $ 1.76 (1.5%) to $ 113.96.

In the industrial drama, GFL Environmental docked $ 1.89 (4.3%) to $ 42.22 and the NFI Group invested 77 cents (2.7%) to $ 28.25.

On Bay Street

The TSX Venture Exchange fell 8.4 points to 933.01.

Eight of the twelve TSX subgroups finished positive on Tuesday, health care increased 1.5%, gold brightened 1.2% and materials improved 0.8%.

The four delays were the heaviest with energy, down 0.9%, while finance and industry each returned 0.6%.

On wall street

US stocks traded near highs on Tuesday after March inflation reports turned out not as bad as some traders feared, but the impact of the Johnson & Johnson vaccine outage is optimistic I suppressed the view.

The 30 Dow Jones Industrial Averages fell more than 150 points early in the session, then fell 68.13 points to end the session at 33,677.27.

The S & P 500 rose 13.6 points to 4,133.49, a new record high.

The Nasdaq Composite rose 146.1 points (1.1%) to 13,996.10 as Apple and PayPal each added more than 2%. Semiconductor maker Nvidia was up 3% and Tesla was up 8.6%.

Pressure was put on Tuesday morning after the US Food and Drug Administration said it recommended suspending the Johnson & Johnson COVID-19 vaccine after reports of blood clots.

FDA Deputy Commissioner Janet Woodcock said late Tuesday that he expected the suspension to last “a few days.” In the United States, more than 6.8 million J & J vaccines have been administered. J & J shares fell 2.4%.

Still, the share of the companies most affected by slow vaccine deployment underperformed on Tuesday.

Both Alaska Airlines and American Airlines lost 1.5%. Car rental company Avis Budget cut by nearly 1%. A strain of Moderna, which makes another coronavirus vaccine, surged 7.4% following the J & J news first reported by the New York Times.

Corporate news will be featured later in the week, with JPMorgan Chase, Goldman Sachs and Delta Air Lines reporting quarterly results.

The Consumer Price Index, one of Wall Street’s most popular inflation indicators, rose 0.6% in March, up 2.6% year-on-year. Economists polled by Dow Jones predicted that the headline index would rise 0.5% month-on-month and 2.5% year-on-year.

The price of 10-year government bonds has risen, with yields declining from 1.67% on Monday to 1.62%. Treasury prices and yields move in the opposite direction.

Oil prices rose 72 cents to US $ 60.42 a barrel.

Gold rose from $ 13.10 to $ 1,745.80 per ounce.

TSX ends flat TSX ends flat

Back to top button